Tenderwize
Zurück zur Suche

Pharmaceutical product Orylmyte (ATC V01AA03 - House dust mites)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Nov 29, 2027 · 460 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Arzneimittel mit der Bezeichnung Orylmyte (ATC-Code: V01AA03 - Hausstaubmilben)

30/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

30 / 100

Komplexität

15 / 100

Risikofaktoren

No guaranteed volumes; actual purchases depend on prescription patterns and discount attractiveness.

Contract can be terminated early if exclusive agreements for the same active substance are signed.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of Orylmyte (ATC V01AA03, house dust mites) finished medicinal products.
  • Conclusion of non-exclusive discount agreements under §130a(8) SGB V.
Vollständige Zusammenfassung anzeigen

This is a non-exclusive discount agreement (open-house model) for the pharmaceutical product Orylmyte (ATC V01AA03, house dust mites) issued by AOK Sachsen-Anhalt. It is not a public procurement under EU/GWB law, but voluntarily published for transparency. Any eligible pharmaceutical company can join any time; no competition or award process. The contract runs max 24 months from 01.02.2026 to 31.01.2028. No estimated value or award criteria are provided. Submission is by signed PDF (qualified electronic signature) via email or postal mail.

Risiken

No guaranteed volumes; actual purchases depend on prescription patterns and discount attractiveness.

Contract can be terminated early if exclusive agreements for the same active substance are signed.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical company or consortium of such companies.

Administrative

  • Must submit the signed participation documents (requested from the contact address).
  • Submission via postal mail or electronic PDF with qualified electronic signature to [email protected].

Anforderungen können unvollständig sein.

Auftraggeber

Ort

Magdeburg, DEU

Auftraggeberprofil

Profil öffnen

Kennung

DE258393558

Tätigkeit

Health

Lose (1)

LOT-0001

Pharmaceutical product Orylmyte (ATC V01AA03 - House dust mites)

Non-exclusive discount agreement for Orylmyte under an open-house model. Any eligible pharmaceutical company can join at any time on identical terms. The contract may be terminated early if AOK Sachsen-Anhalt awards exclusive contracts for the same active substance.

SuppliesEU fundedElectronic submission

Ort

DEE03, Germany

Dauer

2 YEAR

Kategorie

Pharmaceutical products

Frist

Deadline Nov 29, 2027

Vergabedetails

Veröffentlichungsdatum
07 Dec 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
814204-2025

Dokumente (1)

Ähnliche Ausschreibungen